| June 16, 2003 | ||||||||||
In Print![]() Photo by Steve Gilbert
From Focus: HMS researchers have made a discovery that could turn the immune system's dendritic cells into enhanced vaccine agents against AIDS and cancer. Chester Alper, first author Keith Crawford (l to r), and colleagues have identified signals that activate the dendritic cells to perform their T cell targeting duties. By priming this pathway, it may be possible to create dendritic cells that more effectively rouse a patient's T cells to attack specific invaders like cancer cells or HIV.
|
|
HeadlinesStudy Shows Higher Body Mass Index (BMI) Hastens the Progression of Age-related Macular Degeneration Study Suggests More Cancer Patients Receiving Aggressive Care at End-of-Life New Compound Shows Promise When Gleevec Loses Potency in Patients with Rare Digestive-tract Cancer Tight Glucose Control in Diabetes Lowers Risk of Atherosclerosis
UpcomingSocial Medicine Film Screening:An Evening of Reflection to Promote Action on the Global AIDS Pandemic
Paul Farmer, Harvard Medical School |
Spotlight
Student Scene
Lab WorksA multimedia site featuring Harvard Medical research
The 60-second SurveyTake a survey to tell us how you use WebWeekly. |
|||||||
Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home |